FIGS (FIGS) – Investment Analysts’ Weekly Ratings Changes

FIGS (NYSE: FIGS) recently received a number of ratings updates from brokerages and research firms:

• 12/15/2025 – FIGS had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 12/13/2025 – FIGS was downgraded by analysts at Wall Street Zen from a “strong-buy” rating to a “buy” rating.
• 12/10/2025 – FIGS was upgraded by analysts at Wolfe Research to a “buy” rating.
• 12/10/2025 – FIGS had its price target raised by analysts at BTIG Research from $12.00 to $15.00. They now have a “buy” rating on the stock.
• 12/8/2025 – FIGS had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 12/1/2025 – FIGS had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 11/25/2025 – FIGS had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 11/19/2025 – FIGS had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 11/19/2025 – FIGS had its price target raised by analysts at Morgan Stanley from $5.25 to $7.50. They now have an “equal weight” rating on the stock.
• 11/13/2025 – FIGS had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings.
• 11/13/2025 – FIGS had its price target raised by analysts at BTIG Research from $10.00 to $12.00. They now have a “buy” rating on the stock.
• 11/10/2025 – FIGS had its price target raised by analysts at Barclays PLC from $7.00 to $9.00. They now have an “equal weight” rating on the stock.
• 11/7/2025 – FIGS was upgraded by analysts at Weiss Ratings from a “sell (d+)” rating to a “hold (c)” rating.
• 11/7/2025 – FIGS was upgraded by analysts at Zacks Research from a “hold” rating to a “strong-buy” rating.
• 11/7/2025 – FIGS had its price target raised by analysts at The Goldman Sachs Group, Inc. from $5.00 to $5.50. They now have a “sell” rating on the stock.
• 11/7/2025 – FIGS had its price target raised by analysts at BTIG Research from $9.00 to $10.00. They now have a “buy” rating on the stock.
• 11/3/2025 – FIGS had its “market perform” rating reaffirmed by analysts at Telsey Advisory Group. They now have a $9.00 price target on the stock, up previously from $7.00.

Insider Buying and Selling at FIGS

In related news, CEO Catherine Eva Spear sold 62,213 shares of FIGS stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $6.88, for a total value of $428,025.44. Following the transaction, the chief executive officer owned 1,907,033 shares of the company’s stock, valued at approximately $13,120,387.04. This trade represents a 3.16% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Sarah Oughtred sold 22,745 shares of the company’s stock in a transaction dated Tuesday, November 4th. The shares were sold at an average price of $7.39, for a total transaction of $168,085.55. Following the sale, the chief financial officer directly owned 845,345 shares of the company’s stock, valued at $6,247,099.55. This represents a 2.62% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last 90 days, insiders have sold 118,282 shares of company stock valued at $842,076. Corporate insiders own 29.44% of the company’s stock.

FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.